Winona launched a new research initiative to fund and support menopause and women’s health research. The post Winona Launches Menopause Research Initiative appeared first on MedCity News.

Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option. The post Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward appeared first on MedCity News.

The healthcare ecosystem is fixing how quickly decisions get made, without fixing how quickly money actually moves. This isn’t a failure of reform. It’s evidence that reform is working — and revealing where modernization needs to continue. The post The 72-Hour Hurdle: Faster Prior Authorization is Exposing Healthcare’s Broken Billing Cycle appeared first on MedCity News.

The problem isn’t that CQI no longer matters. It’s that traditional approaches were never built for the scale and complexity many agencies are now dealing with. The post Why Traditional CQI Breaks Down as EMS Agencies Grow appeared first on MedCity News.

The challenge isn’t just access to fertility benefits, it’s how those benefits are structured and delivered. Here are three emerging themes that can help employers better align cost, quality and experience. The post The Smart Way to Build the Future of Fertility Benefits appeared first on MedCity News.

The positive ripple effect of high specimen sensitivity influences the clarity of diagnoses, the timing of treatment and the efficiency of care delivery across systems, while also protecting communities from further disease spread for stronger outbreak control. The post Shifting Our Focus to Sample Sensitivity: The Metric That Deserves More Attention in Respiratory Care appeared first on MedCity News.

One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs. The post What the ‘One Nation, Overcharged’ Campaign Aims to Achieve appeared first on MedCity News.

Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer. The post Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer appeared first on MedCity News.

CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027. The post CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery  appeared first on MedCity News.

MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics. The post Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices appeared first on MedCity News.

Millennials and Gen Z are more likely to engage earlier, seek care proactively, and continue treatment over time. A mental health diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded. The post The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing appeared first on MedCity News.

Replacing a paper clipboard with a QR code on your phone doesn’t kill the clipboard; it’s just a better clipboard. Why? The burden is still on the patient. It’s the digital version of carrying a manila folder of records across town. This is a half-measure. It’s not true interoperability. The post Kill the Clipboard Tax appeared first on MedCity News.

AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment. The post AI in Drug Discovery: Surveying the Breadth of the Challenges appeared first on MedCity News.

Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was appeared first on MedCity News.